Origin
Mumbai
Kalbadevi, the historic heart of Mumbai's pharmaceutical and chemical trade. Our offices at Sona Chambers sit at the centre of India's most dynamic science and commerce district.
Polysaccharide Chemistry Pvt Ltd was founded with a clear mandate: to bring polysaccharide-based therapeutics — the most structurally sophisticated class of pharmaceutical compounds — to Indian patients who had long been denied access to them. Our founding team identified a critical gap: India's pharmaceutical industry, despite its generic manufacturing strength, had no local presence in the complex polysaccharide therapeutic space.
Our first act was the development and commercialisation of Elmiron® (Pentosan Polysulfate Sodium), a semi-synthetic polysaccharide derived from beechwood hemicellulose. It is among the best FDA-approved oral therapies for Interstitial Cystitis and Bladder Pain Syndrome — a condition that, in India, had been virtually undiagnosed and entirely untreated. Elmiron® is now available in two formulations: 100mg oral capsules and 50mg/mL intravesical solution, manufactured to international standards.
We are headquartered in Mumbai's Kalbadevi district — a location that speaks to our roots in India's pharmaceutical and chemical trading heritage, combined with our forward-looking clinical mission. Our work sits at the crossroads of organic chemistry, polymer science, clinical pharmacology, and medical education.
Philosophy
Three principles. No compromises.
Molecular Precision
Every therapeutic we develop begins at the molecular level. Polysaccharide chemistry is unforgiving — chain length, sulfation pattern, and degree of substitution each determine clinical outcome. We engineer with exactness.
Clinical Evidence
We do not speculate. Our decisions are grounded in peer-reviewed evidence. 35+ years of PPS data, 7 randomised controlled trials, and a rigorous meta-analysis underpin every clinical claim we make.
Unmet Need
We focus where the system has failed patients — conditions that are misdiagnosed for years, dismissed as psychosomatic, or simply untreatable because no Indian manufacturer had taken the risk. We take the risk.
Registered Office
Sona Chambers, Kalbadevi
Mumbai, India